{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:21:08Z","timestamp":1779358868369,"version":"3.51.4"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease characterized by inflammatory destruction of the intrahepatic bile ducts. The differential diagnosis for PBC often includes autoimmune hepatitis (AIH). Both diseases can show prominent plasma cells and other overlapping histologic features. It is interesting that both diseases can involve elevated levels of serum immunoglobulins, with IgM elevations typical of PBC and IgG elevations typical of AIH. We investigated whether this difference could be useful histologically by immunostaining plasma cells in liver biopsy specimens for IgG and IgM. We examined 56 cases: 18 of PBC and 38 of AIH. In PBC, plasma cells in the portal tracts were predominantly IgM+, whereas in AIH, plasma cells were predominately IgG+ (P &amp;lt; .0001). Immunostaining for IgM and IgG can be helpful in differentiating PBC from AIH.<\/jats:p>","DOI":"10.1309\/ajcp8whr0ievuuoj","type":"journal-article","created":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T02:13:56Z","timestamp":1231899236000},"page":"243-249","source":"Crossref","is-referenced-by-count":50,"title":["Immunostaining of Plasma Cells in Primary Biliary Cirrhosis"],"prefix":"10.1093","volume":"131","author":[{"given":"Jason A.","family":"Daniels","sequence":"first","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Torbenson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Anders","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Boitnott","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,2,1]]},"reference":[{"key":"2023011905502242600_b1-1310243","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM197309272891306","article-title":"The presentation and diagnosis of 100 patients with primary biliary cirrhosis","volume":"289","author":"Sherlock","year":"1973","journal-title":"N Engl J Med"},{"key":"2023011905502242600_b2-1310243","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"2023011905502242600_b3-1310243","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"2023011905502242600_b4-1310243","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"2023011905502242600_b5-1310243","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.111.2.285","article-title":"Immunocytochemical study of gamma globulin in liver in hepatitis and postnecrotic cirrhosis","volume":"111","author":"Cohen","year":"1960","journal-title":"J Exp Med"},{"key":"2023011905502242600_b6-1310243","first-page":"150","article-title":"Local formation of gamma-globulin in the diseased liver, and its relation to hepatic necrosis","volume":"11","author":"Paronetto","year":"1962","journal-title":"Lab Invest"},{"key":"2023011905502242600_b7-1310243","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM196411262712201","article-title":"Immunocytochemical and serologic observations in primary biliary cirrhosis","volume":"271","author":"Paronetto","year":"1964","journal-title":"N Engl J Med"},{"key":"2023011905502242600_b8-1310243","first-page":"33","volume-title":"Gallbladder and Biliary Tract Diseases","author":"Afdhal","year":"2000"},{"key":"2023011905502242600_b9-1310243","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0168-8278(87)80055-7","article-title":"An autoantibody profile in primary sclerosing cholangitis","volume":"5","author":"Zauli","year":"1987","journal-title":"J Hepatol"},{"key":"2023011905502242600_b10-1310243","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2023011905502242600_b11-1310243","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"key":"2023011905502242600_b12-1310243","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","article-title":"Prevalence of non\u2013organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort","volume":"45","author":"Lenzi","year":"1999","journal-title":"Gut"},{"key":"2023011905502242600_b13-1310243","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01296447","article-title":"Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis","volume":"31","author":"Kenny","year":"1986","journal-title":"Dig Dis Sci"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/131\/2\/243\/48762921\/ajcp_131_2_243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/131\/2\/243\/48762921\/ajcp_131_2_243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T05:51:33Z","timestamp":1674107493000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/131\/2\/243\/1766089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,1]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,2,1]]},"published-print":{"date-parts":[[2009,2,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcp8whr0ievuuoj","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,2,1]]},"published":{"date-parts":[[2009,2,1]]}}}